Licensing
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.
Showing 13–24 of 59 articles
Fierce Biotech Week 2026: Key Insights and Highlights
FDA · 6 min
Dr. Sarah MitchellHouse bill aims to crack down on China biotech deals
5 min
Dr. Sarah MitchellASCO Summit: Ivonescimab's China Lung Data Shows Promise, But Global Validation Remains Key
lung · 8 min
Dr. Sarah MitchellVir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM
FDA · 7 min
Dr. Sarah MitchellSTAT+ R&D Performance Ranking: Insights for Pharma Companies
FDA · 7 min
Dr. Sarah MitchellTrumpRx's Generic Drug Expansion: Strategic Implications for the Pharmaceutical Industry
FDA · 8 min
Dr. Sarah MitchellEli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases
genetic kidney diseases · 7 min
Dr. Sarah MitchellOpinion: How the military may be fueling eating disorders in men
eating disorders · 8 min
Dr. Sarah MitchellFDA Approves Xocova: A Catalyst for Pharmaceutical M&A and Licensing
FDA · 8 min
Dr. Sarah MitchellHanmi Signs Licensing Deal with Eli Lilly for Sonefpeglutide, Bolstering GLP-2 Pipeline
FDA · 4 min
Dr. Sarah MitchellSun Pharma and Organon File HSR, Awaiting Antitrust Clearance
7 min
Dr. Sarah MitchellKazia Therapeutics Appoints James Levine as Chief Financial Officer
oncology · 7 min
Dr. Sarah MitchellExplore intelligence